# Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

> **NCT00712504** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 49 (actual)

## Conditions studied

- Advanced Solid Tumors
- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** sunitinib
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00712504
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2008-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00712504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00712504, "Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00712504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*